In vitro activity of a novel compound, the metal ion chelating agent AQ+, against clinical isolates of Staphylococcus aureus | Zendy

Benjamin R. D. Short | Zendy; Miguel Vargas | Zendy; Jonathan C. Thomas | Zendy; Simon J. O’Hanlon | Zendy; Mark C. Enright | Zendy

Open Access

In vitro activity of a novel compound, the metal ion chelating agent AQ+, against clinical isolates of Staphylococcus aureus

Author(s) -

Benjamin R. D. Short,

Miguel Vargas,

Jonathan C. Thomas,

Simon J. O’Hanlon,

Mark C. Enright

Publication year - 2005

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dki428

Subject(s) - staphylococcus aureus , broth microdilution , microbiology and biotechnology , antimicrobial , methicillin resistant staphylococcus aureus , gentamicin , lysis , minimum inhibitory concentration , chemistry , chelation , vancomycin , antibiotics , bacteria , biology , biochemistry , genetics , organic chemistry

To determine the efficacy of a novel antimicrobial compound, AQ+, against a genetically heterogeneous collection comprising 213 Staphylococcus aureus isolates from global sources. AQ+ is an aqueous preparation containing 0.5% 8-hydroxyquinoline.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research